CD68 and hepatocellular carcinoma: At present, a number of studies have reported that CD14+ or CD68+ macrophages have been observed to up-regulate the expression of PD-L1 in a variety of cancer tissues, including hepatocellular carcinoma, melanoma and ovarian cancer [31, 32].